drugset / Trial / NCT00419081
Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment Regimens
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Forodesine Hydrochloride is effective in treating patients with relapsed/refractory precursor T-Lymphoblastic Leukemia/Lymphoma who have failed two or more prior treatment regimens.
Timeline
- Start
- 2006-07
- Primary completion
- 2007-03
- Completion
- 2007-03
Outcome
Outcome not reported
Stopped: “Issues with Manufacturing”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | forodesine | Small molecule | 5 mg/ml | — |
| Subject | forodesine | Small molecule | 100 mg | — |